… of this study To our knowledge, this is the first phase 3 study to compare the efficacy of erlotinib
… These data indicate that the safety profiles of erlotinib plus bevacizumab in this study and …

… using the International Association for the Study of Lung Cancer 7th edition staging system
(… The median PFS observed in the erlotinib arm in our study is similar to the median PFS …

… study showed that erlotinib and gefitinib had similar effectiveness but gefitinib had a better
safety profile compared to erlotinib… for NSCLC patients compared to erlotinib. However, further …

… To our knowledge, our study is the only phase 3 study to … phase 3 study comparing
bevacizumab–erlotinib with erlotinib alone … The overall survival results from these studies will help …

… Firstly, our study enrolled only Japanese patients, therefore we await the results of other
randomized studies with patients treated with the combination of erlotinib plus bevacizumab in …

… study of erlotinib and its … study assessing low-dose erlotinib in elderly or frail patients with
EGFR mutation–positive NSCLC. We verified the clinical efficacy of low-dose erlotinib in these …

… of the study was to increase the efficacy of erlotinib against erlotinib-resistant non-small cell
lung cancer… For this purpose, cytotoxicity of developed NPs was evaluated in both erlotinib …

… within the first month of treatment because of intolerance, whereas four patients
continued erlotinib beyond 2 years (off study) because of patient or physician preference. …

… , and erlotinib are recommended … study is to investigate how afatinib is used in real-world
practice, and whether it leads to different clinical outcomes compared with gefitinib or erlotinib…

… However, erlotinib-resistant lung cancer remains an unsolved … of erlotinib together with
their anticancer activity studies against erlotinib-sensitive A549 and H1395 as well as erlotinib-…